$201 Million is the total value of SevenBridge Financial Group, LLC's 134 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RTN | New | Raytheon Technologies Ordequities | $1,568,000 | – | 25,450 | +100.0% | 0.78% | – |
BNTX | New | BIONTECH SE ADRequities | $1,243,000 | – | 18,627 | +100.0% | 0.62% | – |
TER | New | Teradyne Incequities | $841,000 | – | 9,956 | +100.0% | 0.42% | – |
ADI | New | Analog Devices Incequities | $418,000 | – | 3,405 | +100.0% | 0.21% | – |
OLLI | New | Ollie s Bargain Outlet Holdings Incequities | $242,000 | – | 2,475 | +100.0% | 0.12% | – |
WORK | New | Slack Technologies Incequities | $240,000 | – | 7,714 | +100.0% | 0.12% | – |
IWM | New | iShares Russell 2000equities | $239,000 | – | 1,672 | +100.0% | 0.12% | – |
PAYX | New | Paychex Incequities | $231,000 | – | 3,054 | +100.0% | 0.12% | – |
VEA | New | Vanguard FTSE Developed Markets ETFequities | $225,000 | – | 5,797 | +100.0% | 0.11% | – |
ALB | New | Albemarle Corpequities | $222,000 | – | 2,873 | +100.0% | 0.11% | – |
GILD | New | Gilead Sciences Incequities | $205,000 | – | 2,667 | +100.0% | 0.10% | – |
BRO | New | Brown & Brown Incequities | $203,000 | – | 4,978 | +100.0% | 0.10% | – |
MKC | New | McCormick & Co Inc Non-Votingequities | $200,000 | – | 1,114 | +100.0% | 0.10% | – |
UAA | New | Under Armour Inc Aequities | $129,000 | – | 13,281 | +100.0% | 0.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-07-24
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Alphabet Inc Class A Common Stock | 31 | Q3 2023 | 4.3% |
PFIZER INC COM | 31 | Q3 2023 | 2.2% |
HONEYWELL INTL INC COM | 31 | Q3 2023 | 1.1% |
Visa Inc Class A | 31 | Q3 2023 | 1.2% |
LOCKHEED MARTIN CORP | 31 | Q3 2023 | 1.1% |
Walt Disney Co | 31 | Q3 2023 | 1.7% |
Usbancorp Del Com | 31 | Q3 2023 | 1.1% |
Meta Platforms Inc Class A | 31 | Q3 2023 | 1.1% |
Bristol-Myers Squibb Company | 31 | Q3 2023 | 1.1% |
NEXTERA ENERGY INC COM | 31 | Q3 2023 | 1.2% |
View SevenBridge Financial Group, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-10 |
13F-HR | 2024-01-22 |
13F-HR | 2023-10-25 |
13F-HR | 2023-07-26 |
13F-HR | 2023-04-20 |
13F-HR | 2023-01-26 |
13F-HR | 2022-10-17 |
13F-HR | 2022-07-12 |
13F-HR | 2022-04-15 |
13F-HR/A | 2022-01-20 |
View SevenBridge Financial Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.